Cargando…
Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition
Bergamottin (BGM) is a naturally occurring furanocoumarin and is known to inhibit the growth of tumor cells. However, there is no available evidence that BGM has an inhibitory effect on cancer metastasis, specifically on the epithelial-to-mesenchymal transition (EMT) process in the malignant cells....
Autores principales: | Ko, Jeong-Hyeon, Nam, Dongwoo, Um, Jae-Young, Jung, Sang Hoon, Sethi, Gautam, Ahn, Kwang Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100248/ https://www.ncbi.nlm.nih.gov/pubmed/30004418 http://dx.doi.org/10.3390/molecules23071601 |
Ejemplares similares
-
A Novel Role of Bergamottin in Attenuating Cancer Associated Cachexia by Diverse Molecular Mechanisms
por: Jung, Young Yun, et al.
Publicado: (2021) -
Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018) -
Procaine Abrogates the Epithelial-Mesenchymal Transition Process through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma
por: Yang, Min Hee, et al.
Publicado: (2022) -
2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells
por: Jung, Young Yun, et al.
Publicado: (2022) -
Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade
por: Hwang, Sun Tae, et al.
Publicado: (2020)